The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
暂无分享,去创建一个
K. D. Sørensen | H. Brenner | H. Grönberg | M. Kogevinas | A. Wolk | R. Eeles | Z. Kote-Jarai | K. Muir | C. Haiman | J. Schleutker | D. Neal | J. Stanford | S. Ingles | E. John | Jong Y. Park | C. Maier | R. Kaneva | M. Southey | J. Batra | C. Tangen | A. Kibel | D. Albanes | O. Cussenot | F. Wiklund | S. Berndt | B. Nordestgaard | M. Roobol | S. F. Nielsen | S. Neuhausen | C. Logothetis | F. Claessens | K. Penney | P. Townsend | C. West | D. Lessel | N. Usmani | B. Rosenstein | L. Mucci | R. Hamilton | L. Newcomb | Stella Koutros | R. Travis | N. Pashayan | C. Cybulski | M. Teixeira | P. Paulo | S. Maia | M. Gago-Domínguez | E. Grindedal | A. Vega | Marta Cardoso | A. Razack | A. Peixoto | M. Pinheiro | Catarina Santos | Andreia Brandão | the PRACTICAL consortium | Ying Wang | K. D. Ruyck | Maria P. Silva | Ukgpcs Collaborators | Apcb BioResource | The Impact Study Steering Committee And Collaborat | Canary Pass Investigators | The Profile Study Steering Committee | K. Ruyck | Ana Peixoto | M. Teixeira | Lisa F. Newcomb | C. Santos